Company: CERO
Filing Date: 2025-12-05
Form Type: S-1
Source: 0001213900-25-118817
Chunk: 431

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-12-05
Form: S-1
Chunk 431
---
 fundamental transactions unless the Successor assumes all of our obligations under the Preferred Warrants
under a written agreement before the transaction is completed. Upon specified corporate events, a holder of the Preferred Warrants thereafter
had the right to receive upon an exercise such shares, securities, cash, assets or any other property whatsoever which the holder would
have been entitled to receive upon the happening of the applicable corporate event had the Preferred Warrant been exercised immediately
prior to the applicable corporate event.

During the period from February
14, 2024 through December 31, 2024, Series A Preferred Warrants were exercised into shares of Series A Preferred Stock for
gross proceeds of $. The remaining Series A Preferred Warrants were exercised in January 2025 for gross proceeds of $
(See Note 14).

The Company’s Preferred
Warrants were exercisable into Series A Preferred Stock, which had no cash redemption features that required liability treatment. The
Company recorded the Preferred Warrants as equity.

A summary of outstanding
warrants as of December 31, 2024 is as follows:

|                                         |     | Number of 
 Warrants  |        |     | Weighted 
 Average  
 Exercise 
 Price    |           |     | Weighted         
 Average          
 Remaining        
 Contractual Life 
 (in years)       |      |
|:----------------------------------------|:----|:----------|-------:|:----|:---------|----------:|:----|:-----------------|-----:|
| Public Warrants                         |     |           |  4,596 |     | $        | 23,000.00 |     |                  | 4.13 |
| February 2024 Series A Common Warrants  |     |           |    306 |     |          |  2,780.00 |     |                  | 2.62 |
| Series A Preferred Warrants             |     |           |    625 |     |          |    800.00 |     |                  | 0.12 |
| September 2024 Series C Common Warrants |     |           |  4,088 |     |          |    196.00 |     |                  | 3.23 |
| December 2024 Common Warrants           |     |           |  4,203 |     |          |    112.20 |     |                  | 3.48 |
| Outstanding as of December 31, 2024     |     |           | 13